Cornerstone Robotics

What Cornerstone Robotics does

Cornerstone Robotics is a Hong Kong-headquartered surgical robotics company founded in September 2019 that develops full-stack endoscopic surgical robotic systems targeting the Chinese market and global expansion. The company's flagship product is the Sentire® Endoscopic Surgical Robotic System (C1000), which integrates in-house mechanical, electrical, software, algorithmic, and vision/imaging architectures (the underlying SRF platform) into a unified system covering urology, gynecology, general surgery, thoracic surgery, and hepato-biliary-pancreatic procedures. Complementary products include the CV2000 4K 3D endoscope (NMPA-registered with two certificates) and a portfolio of proprietary surgical instruments including 5mm micro wristed instruments and dual-force closure instruments. Technical differentiators include 600-degree wrist rotation, ultra-low latency master-slave control, active tremor filtration, immersive naked-eye 3D vision with 10x magnification, and AI-powered autonomous capabilities developed in collaboration with CUHK researchers.

The company operates a direct enterprise sales model selling capital equipment to hospitals through regional sales teams covering Hong Kong, mainland China (Beijing and Shanghai offices), Asia-Pacific, the UK (Portsmouth subsidiary established 2025), Europe, and globally. Revenue is generated through three streams: capital equipment sales (Sentire system and CV2000 endoscope), consumables and instruments, and after-sales service and professional training. Go-to-market is anchored by clinical KOL partnerships with leading academic hospitals, multi-regional regulatory approvals (NMPA September 2024, EU CE MDR May 2026, Singapore HSA May 2026), surgeon training programs at top institutions (CUHK, CUHK-Shenzhen, Portsmouth NHS Trust, NHG Singapore), and conference presence at EAU, CUA, and Medtec. Manufacturing is anchored by a 30,000-square-meter facility in Shenzhen's Greater Bay Area.

The company has raised over $270 million in disclosed funding across multiple rounds (cumulative across all rounds exceeds $475 million), achieving unicorn valuation, and has demonstrated clinical differentiation through milestone events including the world's first multi-site intercontinental robotic telesurgery across Shanghai-Hong Kong-London in July 2025 and the world's first clinical autonomous surgery verification published in Science Robotics in August 2025. Portsmouth Hospitals University NHS Trust has completed over 5,000 robotic procedures using the Sentire system, establishing a scalable NHS adoption model. Strategic investors include EQT (Series C lead), Hong Kong Investment Corporation (HKIC, November 2025 round lead), Qiming Venture Partners, Alpha JWC Ventures, and the Hong Kong SAR Government Innovation and Technology Venture Fund.

Name

Cornerstone Robotics

Legal name

Cornerstone Robotics Limited

Website

https://csrbtx.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

251–500 employees

Short description

Hong Kong-based surgical robotics company founded in 2019 developing the Sentire® Endoscopic Surgical Robotic System and CV2000 4K 3D endoscope for minimally invasive procedures across urology, gynecology, general, and thoracic surgery, with NMPA, EU CE MDR, and Singapore HSA approvals serving hospitals globally.

Ownership category

akta.pro rank

Product category

Surgical Robotics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Healthcare & Assistive Robotics (HDAAAIAC), Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Surgical robotics systems
• Endoscopic surgical robots
• Robotic-assisted surgery
• Laparoscopic surgical platforms
• Minimally invasive surgery devices

Headquarters

HQ city

Hong Kong

HQ country

Hong Kong SAR China

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Surgical Robotic System Sales (Capital Equipment): Sale of the Sentire Endoscopic Surgical System (C1000) and CV2000 4K 3D endoscope to hospitals. Direct enterprise sales model with regional sales teams in Hong Kong, Asia-Pacific, UK, Europe, and globally. Revenue recognized upon system installation and commissioning at customer sites.
2. Surgical Instruments and Consumables: Sale of surgical instruments (long-life, flexible, multi-functional) that are consumed during procedures. The company produces and sells instrument sets compatible with the Sentire system. Additionally, consumables for the CV2000 endoscope system are sold alongside the hardware.
3. After-Sales Service and Support: After-sales technical support, maintenance, and professional education/training services. The company provides professional education programs for surgeons (online courses, simulator training, dry lab, animal lab, advanced courses) and surgical team training (operation training). Service hotline and email support are available regionally.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Cornerstone Robotics designs, manufactures, and sells the Sentire Endoscopic Surgical System (C1000), a full-stack minimally invasive surgical robotics platform for urology, gynecology, general surgery, and thoracic surgery. The company also sells the complementary CV2000 4K 3D electronic endoscope and proprietary wristed surgical instruments, and provides professional training and after-sales support services to hospitals and surgical teams globally.

Product overview

Cornerstone Robotics offers a unified surgical robotics platform anchored by the Sentire Endoscopic Surgical Robotic System (C1000), a flagship product for minimally invasive procedures. The portfolio includes the CV2000 4K 3D endoscope as a complementary imaging component and compatible surgical instruments. The system is indicated for general surgery, gynecology, thoracic surgery, and urology across China (NMPA), EU (CE Mark MDR), and Singapore (HSA).

Differentiator

Problem solved

Functional benefit

Brands

• Sentire思腾: Endoscopic surgical robotic system brand; the company's flagship product featuring AI-powered autonomous capabilities for minimally invasive procedures across general surgery, gynecology, thoracic, and urology
• CV2000
• SRF

Products and services

• Sentire Endoscopic Surgical Robotic System (C1000) High-end surgical robotic platform combining clinical workflows with integrated engineering, software, and imaging technologies to support surgeons in performing complex minimally invasive procedures. Features 600° wrist rotation, 27L master workspace, 10x magnified immersive naked-eye 3D vision, dual-force closure feedback, ultra-low latency, active tremor filtration, anti-fog design, and integrated cold light source. Indicated for urology, gynecology, general surgery, and thoracic surgery. Sold to hospitals and surgical departments as capital equipment.
• CV2000 4K 3D Endoscope 4K ultra-high definition 3D electronic thoracoscope and laparoscope with integrated image processing and lighting source. Features 3840x2160 resolution, intelligent noise reduction, auto white balance, auto light control, dual optical path true 3D, sapphire lens with soldered structure (IPX7 waterproof), and anti-fog design. Sells alongside the Sentire system as a complementary imaging component for hospitals.
• Sentire Surgical Instruments (5mm and 8mm Wristed Instruments) Long-life, flexible, and durable surgical instruments compatible with the Sentire system, including proprietary 5mm and 8mm robotic instruments with 600° wrist articulation enabling access to narrow surgical spaces. Sold as instrument sets and consumables used during procedures.
• Professional Surgical Training and After-Sales Service Programs Professional education programs for surgeons and clinical teams covering online courses, simulator training, dry lab, animal lab, and advanced courses, along with operation training for surgical teams. After-sales technical support, maintenance, and service hotline/email support are provided regionally. Sold to hospitals as part of system adoption and recurring service agreements.

Quantifiable outcome

• Clinical trial success rate of 100% with no changes to surgical method or complications in mainland China multi-center trials (covering radical prostatectomy, partial nephrectomy, pyeloplasty)
• +4 more outcomes

Named customers9 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Partnerships

Ten partnerships are on record, tiered core, major and minor.

• National Healthcare Group (NHG) and Nanyang Technological University Singapore — Lee Kong Chian School of Medicine (LKCMedicine)coreStrategic or Co-development Partner · 17 July 2025Cornerstone Robotics signed a tripartite MOU with NHG and NTU Singapore (LKCMedicine) in July 2025 to collaborate on robotic-assisted surgery clinical research, surgical education, and healthcare innovation. The partnership focuses on tele-surgical education and training research, and cost-effectiveness studies to facilitate extending RAS accessibility in Singapore. The MOU was witnessed by Singapore's Minister for Health Mr. Ong Ye Kung. In April 2026, the first Sentire system was installed at Woodlands Hospital under NHG for training and clinical workflow assessment.
• Renji Hospital of Shanghai Jiao Tong UniversitymajorStrategic or Co-development Partner · 17 July 2025Renji Hospital's surgical team (led by Prof. Zhang Zhizhen) participated in the world's first multi-site intercontinental robotic telesurgery (20,000 km, Shanghai-Hong Kong-London) using the Sentire system in July 2025. This collaboration demonstrates tele-surgical capability and positions the system for advanced clinical applications.
• Imperial College London / The Royal Marsden HospitalmajorStrategic or Co-development Partner · 17 July 2025Imperial College London's surgical team (led by Prof. Asif Chaudry, Hamlyn Centre) participated in the world's first multi-site intercontinental robotic telesurgery (Shanghai-Hong Kong-London) alongside Cornerstone's Sentire system. The Royal Marsden Hospital, a world-leading cancer center, collaborated on this landmark tele-surgical demonstration.
• Hamlyn Centre, Imperial College LondonmajorStrategic or Co-development Partner · 17 July 2025The Hamlyn Centre at Imperial College London, a leading medical robotics research center, collaborated with Cornerstone and CUHK's InnoHK Multi-Scale Medical Robotics Center on the world's first multi-site intercontinental robotic telesurgery. This partnership combines world-class medical robotics research expertise with Cornerstone's surgical platform.
• InnoHK Multi-Scale Medical Robotics Center (MRC)coreTechnology or Integration · 17 July 2025The InnoHK Multi-Scale Medical Robotics Center, established at CUHK with government funding, is a global top-tier research laboratory. Cornerstone Robotics' founder Prof. Samuel Au serves as co-chair of this center. The collaboration focuses on clinical research, next-generation surgical robotics, and remote tele-surgical technology. Cornerstone completed multiple animal and cadaver experiments and clinical applications at this center.
• Portsmouth Hospitals University NHS Trust (PHU)coreStrategic or Co-development Partner · 30 June 2025PHU partnered with Cornerstone Robotics in June 2025 to conduct the first formal clinical investigation of the Sentire Endoscopic Surgical System in the UK and Europe at Queen Alexandra Hospital. Led by Prof. Jim Khan, the trial covered colorectal and urological procedures. PHU is an international leader in surgical robotics with over 5,000 completed robotic procedures and the UK's first dedicated robotic-assisted day surgery program. This partnership provides European clinical data, regulatory validation, and a training base for UK/EU market entry.
• Second Affiliated Hospital of Xi'an Jiaotong UniversitymajorStrategic or Co-development Partner · 23 April 2025Prof. Xue Li's team at Xi'an Jiaotong University Second Affiliated Hospital successfully performed a high-difficulty single-position multi-site malignancy surgery (kidney, ureter, bladder) using Cornerstone's surgical robot. This case validated the clinical performance of Cornerstone's system in complex urological procedures.
• UBS Group (financial advisor)minorOthers · 13 January 2025UBS Group served as financial advisor for both the January 2025 Series C and the November 2025 ~US$200M financing rounds.
• Chinese University of Hong Kong (Shenzhen) — School of MedicinecoreStrategic or Co-development Partner · 7 June 2024Cornerstone Robotics signed a strategic cooperation framework with CUHK-Shenzhen School of Medicine in June 2024 to jointly build a 'world-class minimally invasive surgery and surgical robot teaching base.' The partnership covers platform construction, educational training, and scientific research. This collaboration leverages the Greater Bay Area's manufacturing and AI capabilities to advance surgical robotics education and clinical application in southern China.
• CUHK Faculty of Medicine / Prince of Wales HospitalcoreStrategic or Co-development Partner · 1 August 2022The Chinese University of Hong Kong Faculty of Medicine has partnered with Cornerstone since August 2022 for clinical trials of the Sentire system at Prince of Wales Hospital. Prof. Philip Chiu Wai-yan (Dean of CU Medicine) and Prof. Francis KL Chan led clinical collaborations. A December 2024 MOU expanded the partnership to include research, training, clinical applications, and next-generation robotic and remote tele-surgical technology development. The partnership leverages CUHK's InnoHK Multi-Scale Medical Robotics Center.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Intuitive Surgical: The global leader in surgical robotics with the da Vinci platform, dominating minimally invasive robotic surgery across urology, gynecology, general surgery, and thoracic. Direct competitor to Cornerstone's Sentire system in the same indications and hospital customer base, with the most entrenched installed base and surgeon training ecosystem.
• MicroPort MedBot (Toumai): Chinese surgical robotics subsidiary of MicroPort Scientific developing the Toumai laparoscopic robotic system for similar urology, gynecology, thoracic, and general surgery indications. Direct domestic Chinese competitor with overlapping NMPA regulatory footprint and shared hospital target market.
• CMR Surgical (Versius): UK-based surgical robotics company with the Versius laparoscopic robotic system approved for use across gynecology, general surgery, urology, and thoracic indications. Direct comparable peer competing for European hospital adoption with similar multi-specialty positioning to Cornerstone's Sentire.

Broad incumbents

• Medtronic: Diversified medtech giant that has developed the Hugo robotic-assisted surgery platform targeting the same laparoscopic indications (urology, gynecology, general surgery) as Cornerstone's Sentire. Comparable as a direct robotic surgery competitor from a much larger incumbent with broader hospital relationships.
• Johnson & Johnson (Ottava): Healthcare conglomerate developing the Ottava multi-port robotic surgery platform as part of its broader medtech portfolio. Broad incumbent comparable due to overlapping robotic surgery strategy and vast hospital relationships, even as its platform is still pre-commercial.
• Stryker (Mako): Established orthopedic robotics leader with the Mako platform for joint replacement. Broad incumbent medtech comparable through shared surgical robotics DNA and hospital procurement channels, even though its primary focus is orthopedic rather than laparoscopic surgery.

Emerging players

• Edge Medical Robotics: China-based surgical robotics company developing endoscopic robotic platforms for minimally invasive surgery. Emerging direct peer in the Chinese surgical robotics competitive landscape with comparable technology profile and target indications.
• Shurui Robot: Chinese surgical robotics developer focused on laparoscopic robotic systems. Comparable emerging Chinese peer competing for the same NMPA-approved robotic surgery market in urology, gynecology, and general surgery.
• Moon Surgical: European-headquartered surgical robotics company developing a collaborative laparoscopic robotic platform. Comparable emerging competitor targeting the same minimally invasive surgical robotics space with focus on surgeon-friendly design.
• Asensus Surgical (Senhance): Surgical robotics company developing the Senhance laparoscopic platform with digital surgery features. Comparable emerging competitor in robotic-assisted laparoscopic surgery targeting similar general surgery and gynecology indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cornerstone-robotics-limited/posts/?feedView=all

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds6 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cornerstone Robotics